Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 73, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2022.128918
Keywords
Technetium-99m; Alendronate; Pamidronate; Isocyanide; Bone imaging
Categories
Funding
- National Natural Science Foundation of China [22076013, 21771023]
- project of Beijing Municipal Science and Technology Commission [Z181100002218033]
Ask authors/readers for more resources
Novel bone imaging agents were developed by synthesizing bisphosphonate isocyanide derivatives and radiolabeling them with Tc-99m. The [Tc-99m] Tc-CNALN complex showed high stability and bone/background ratio, making it a promising bone-seeking agent.
In order to develop Tc-99m-labeled complexes with bisphosphonate isocyanide as novel bone imaging agents, two bisphosphonate isocyanide derivatives (CNALN and CNPAM) were synthesized and radiolabeling was performed for preparing the corresponding [Tc-99m]Tc(I) complexes. [Tc-99m]Tc-CNALN and [Tc-99m]Tc-CNPAM were obtained with high radiochemical purity and showed good in vitro stability. Both of them were hydrophilic and had high affinity to hydroxyapatite. The biodistribution studies in mice revealed [Tc-99m]Tc-CNALN showed higher bone/background ratios at 60 min post-injection. In single photon emission computed tomography (SPECT) imaging study, [Tc-99m]Tc-CNALN had an obvious accumulation in bone, suggesting it would be a promising bone-seeking agent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available